Examining the link between ultrasound measured eye nerve size and the timing of discontinuing magnesium sulphate treatment in pre-eclamptic patients with severe features – A preliminary observation study
Not Applicable
- Conditions
- Health Condition 1: O141- Severe pre-eclampsia
- Registration Number
- CTRI/2024/02/063264
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Pregnant patients aged =18 years
Period of gestation = 20 weeks
Presenting with pre-eclampsia with severe features
Patients who will receive MgSO4 therapy
Planned for termination of pregnancy
Exclusion Criteria
Patient’s refusal
Eclamptic patients
Patient who receives MgSO4 prior to first reading of optic nerve sheath diameter.
Patients who have undergone previous cranial or eye surgeries
Patients suffering from seizures, intracranial or eye pathology, glaucoma or any other
neurological condition.
Patients with uncontrolled diabetes or cardiac disease
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method